Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Shariat

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Urology|October 22, 2011
Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinomaS Brookman-May, M May, R Zigeuner, et al.
Actas Urologicas Espanolas|June 20, 2021
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patientsF Pisano, P Gontero, R Sylvester, et al.
World Journal of Urology|May 4, 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thoughtJ Palou, F Pisano, R Sylvester, et al.
World Journal of Urology|August 25, 2017
Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patientsH Borgmann, M Musquera, A Haferkamp, et al.
World Journal of Urology|September 2, 2018
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomyFrancesco Soria, Francesca Pisano, Paolo Gontero, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 23, 2016
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA databaseI Wolff, M May, B Hoschke, et al.
British Journal of Cancer|July 9, 2014
Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessmentL A Kluth, F Abdollah, E Xylinas, et al.
European Urology Open Science|August 1, 2022
Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at SurgeryFrancesco Soria, B Pradere, R Hurle, et al.
European Urology Focus|February 19, 2022
Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54]Maria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2016
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatmentD Pouessel, Y Neuzillet, L S Mertens, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Urology|October 22, 2011
Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinomaS Brookman-May, M May, R Zigeuner, et al.
Actas Urologicas Espanolas|June 20, 2021
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patientsF Pisano, P Gontero, R Sylvester, et al.
World Journal of Urology|May 4, 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thoughtJ Palou, F Pisano, R Sylvester, et al.
World Journal of Urology|August 25, 2017
Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patientsH Borgmann, M Musquera, A Haferkamp, et al.
World Journal of Urology|September 2, 2018
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomyFrancesco Soria, Francesca Pisano, Paolo Gontero, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 23, 2016
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA databaseI Wolff, M May, B Hoschke, et al.
British Journal of Cancer|July 9, 2014
Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessmentL A Kluth, F Abdollah, E Xylinas, et al.
European Urology Open Science|August 1, 2022
Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at SurgeryFrancesco Soria, B Pradere, R Hurle, et al.
European Urology Focus|February 19, 2022
Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54]Maria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2016
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatmentD Pouessel, Y Neuzillet, L S Mertens, et al.
Pageof 10